Arcus Biosciences
Quarterly Financials
| Values in thousands | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 |
|---|---|---|---|---|
Revenue | $39,000 | $145,000 | $31,000 | $32,000 |
Gross Profit | 37,000 | 142,000 | 26,000 | 29,000 |
EBITDA | -104,000 | 20,000 | -77,000 | -68,000 |
EBIT | -106,000 | 17,000 | -82,000 | -71,000 |
Net Income | -93,000 | -4,000 | -81,000 | -71,000 |
Net Change In Cash | 39,000 | 145,000 | 31,000 | 32,000 |
Free Cash Flow | -94,000 | -6,000 | -94,000 | -73,000 |
Cash | 156,000 | 185,000 | 127,000 | 184,000 |
Basic Shares | 91,100 | 86,200 | 75,000 | 74,600 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $117,000 | $112,000 | $382,882 | $77,517 |
Gross Profit | 101,000 | 98,000 | 375,825 | -81,483 |
EBITDA | -291,000 | -264,000 | 54,905 | -124,848 |
EBIT | -307,000 | -278,000 | 47,848 | -129,239 |
Net Income | -307,000 | -267,000 | 53,000 | -116,677 |
Net Change In Cash | 117,000 | 112,000 | 382,882 | 77,517 |
Cost of Revenue | -22,699 | 115,478 | ||
Free Cash Flow | -330,000 | 426,000 | -282,249 | 108,115 |
Cash | 127,000 | 206,000 | 147,914 | 173,415 |
Basic Shares | 74,000 | 72,000 | 73,966 | 54,787 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-06-30 | -$1.02 |
2024-03-31 | -$0.05 |
2023-12-31 | -$1.08 |
2023-09-30 | -$0.94 |
